BIO-Europe Spring® 2017: Key considerations in microbiome partnering

March 29, 2017
The human microbiome is garnering research interest across the globe and industry is responding to the growing possibilities of therapeutic developments in a variety of ways, a key aspect of which is partnerships. The current state of play means emerging companies are often looking for specific expertise or experience in their partners, often influenced by the variety of approaches under different regulatory jurisdictions or financial structures.
Previous Video
BIO-Europe Spring® 2017: Incorporating flexibility into your R&D strategy
BIO-Europe Spring® 2017: Incorporating flexibility into your R&D strategy

Strategic decisions made early in clinical development often have an impact on the downstream commercial po...

Next Article
Biotechs successfully navigate alternative paths to financing
Biotechs successfully navigate alternative paths to financing

Project awards, strategic venture funds and now crowd-funding offer alternatives to traditional venture fun...